4//SEC Filing
FIBROGEN INC 4
Accession 0001209191-16-112563
$FGENCIK 0000921299operating
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 6:53 PM ET
Size
10.8 KB
Accession
0001209191-16-112563
Insider Transaction Report
Form 4
FIBROGEN INCFGEN
VALONE FRANK H MD
Chief Medical Officer
Transactions
- Sale
Common Stock
2016-04-01$21.47/sh−200$4,294→ 104,684 total - Exercise/Conversion
Stock Option (Right to Buy)
2016-04-01−10,750→ 2,722 totalExercise: $3.92Exp: 2019-08-11→ Common Stock (10,750 underlying) - Exercise/Conversion
Common Stock
2016-04-01$3.92/sh+10,750$42,194→ 115,434 total - Sale
Common Stock
2016-04-01$21.10/sh−10,550$222,647→ 104,884 total
Holdings
- 4,000(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]Shares sold pursuant to a 10b5-1 plan.
- [F2]The shares were sold at prices between $20.47 and $21.46. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]Fully vested.
Documents
Issuer
FIBROGEN INC
CIK 0000921299
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000921299
Filing Metadata
- Form type
- 4
- Filed
- Apr 3, 8:00 PM ET
- Accepted
- Apr 4, 6:53 PM ET
- Size
- 10.8 KB